StockData
P3 Health Partners Inc. logo

P3 Health Partners Inc. (PIIIW) stock

PIIIWNasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIII
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/30
$0.01+0.00 (+14.89%)

Close on Oct 30, 2026Market cap $29.26MP/E –Yield –

Earnings

P3 Health Partners's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 13, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$386.00M
+8.5% on a year earlier
EPS, Q2 FY2026
–
-$6.23 a year earlier
Latest guidance
Issued
May 14, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of P3 Health Partners's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 13, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 10, 2026after the close$386.00M+8.5%–Release
Q1 FY2026ended Mar 31, 2026May 14, 2026after the close$386.00M+3.4%$0.32Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026after the close$384.80M+3.8%–Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025after the close$345.30M-4.6%-$9.67Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025after the close$355.80M-6.2%-$6.23Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close$373.20M-3.9%-$6.28Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025after the close$370.70M+6.9%–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$362.10M+25.6%–Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close$379.20M+16.5%-$0.15Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close$388.50M+28.6%-$0.16Release
Q4 FY2023ended Dec 31, 2023Mar 28, 2024after the close$346.90M+36.6%-$0.22Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

P3 Health Partners's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total Revenues (in millions)FY2026$1.50B – $1.65B–NewMay 14, 2026
Adjusted EBITDA (1)(3) (in millions)non-GAAPFY2026$20.00M – $60.00M–NewMay 14, 2026
At-risk MembersFY2026103,000 – 110,000–NewMay 14, 2026
Medical Margin (1)(3) (in millions)non-GAAPFY2026$190.00M – $230.00M–NewMay 14, 2026
Medical Margin (1)(3) PMPMnon-GAAPFY2026149 – 180–NewMay 14, 2026

Guidance vs results

The last range P3 Health Partners gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$1.40B – $1.45B$1.46BΣ4QAbove range

Guidance history

Every forecast P3 Health Partners put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
May 14, 2026Adjusted EBITDA (1)(3) (in millions)FY2026$20.00M – $60.00MNew
May 14, 2026Medical Margin (1)(3) (in millions)FY2026$190.00M – $230.00MNew
May 14, 2026At-risk MembersFY2026103,000 – 110,000New
May 14, 2026Medical Margin (1)(3) PMPMFY2026149 – 180New
May 14, 2026Total Revenues (in millions)FY2026$1.50B – $1.65BNew
Nov 13, 2025Adjusted EBITDAFY2025-$110.00M – -$95.00MNew
Nov 13, 2025At-risk MembersFY2025112,000 – 117,000New
Nov 13, 2025Medical Margin PMPMFY2025$48 – $59Lowered
Nov 13, 2025Medical MarginFY2025$67.00M – $82.00MNew
Nov 13, 2025Total RevenuesFY2025$1.40B – $1.45BNew
Aug 14, 2025Adjusted EBITDAFY2025-$69.00M – -$39.00MLowered
Aug 14, 2025Medical MarginFY2025$124.00M – $154.00MNew
Aug 14, 2025At-risk MembersFY2025109,000 – 119,000Reaffirmed
Aug 14, 2025Medical Margin PMPMFY2025$90 – $111Lowered
Aug 14, 2025Total RevenuesFY2025$1.35B – $1.50BNew
May 15, 2025Adjusted EBITDAFY2025-$35.00M – $5.00MNew
May 15, 2025Medical MarginFY2025$174.00M – $210.00MNew
May 15, 2025Medical Margin PMPMFY2025$133 – $147Lowered
May 15, 2025At-risk MembersFY2025109,000 – 119,000New
May 15, 2025Total RevenuesFY2025$1.35B – $1.50BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases P3 Health Partners filed with the SEC as exhibits to Form 8-K or 6-K

  1. P3 Health Partners Announces Second Quarter 2026 Results
    Results
  2. P3 HEALTH PARTNERS INC. and SUBSIDIARIES
    News
  3. P3 Health Partners Announces First Quarter 2026 Results
    Results
  4. P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
    Results
  5. P3 Health Partners Announces Third Quarter 2025 Results
    Results
  6. P3 Health Partners Announces Second Quarter 2025 Results
    Results
  7. P3 Health Partners Announces First Quarter 2025 Results
    Results
  8. P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results
    Results
  9. P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
    Update
  10. P3 Health Partners Announces Third Quarter 2024 Results
    Results
  11. P3 Health Partners Announces Second Quarter 2024 Results
    Results
  12. P3 Health Partners Announces First Quarter 2024 Results
    Results
  13. P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results
    Results
  14. P3 Health Partners Reaffirms Guidance for 2023 and
    Results
  15. REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    News